Differential regulation of eotaxin-1/CCL11 and eotaxin-3/CCL26 production by the TNF-α and IL-4 stimulated human lung fibroblast

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 6, 2006, Pages 1102-1109

  Rokudai, Akiko ^a,b   Terui, Yasuhito ^a   Kuniyoshi, Ryoko ^a,b   Mishima, Yuji ^a   Mishima, Yuko ^a   Aizu Yokota, Eriko ^b   Sonoda, Yoshiko ^b   Kasahara, Tadashi ^b   Hatake, Kiyohiko ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Eotaxin 1; Eotaxin 3; Lung fibroblast; NF B activation; Proteasome inhibitor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BORTEZOMIB; CHEMOKINE; EOTAXIN; EOTAXIN 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; N ACETYLLEUCYLLEUCYLNORLEUCINAL; PROTEASOME INHIBITOR; RECOMBINANT PROTEIN; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IC 50; IMMUNOPATHOLOGY; LUNG FIBROBLAST; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; SENSITIVITY ANALYSIS;

ASTHMA; BORONIC ACIDS; CELL LINE; CHEMOKINE CCL11; CHEMOKINES, CC; DRUG SYNERGISM; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; HYPERSENSITIVITY; IMMUNOBLOTTING; INTERLEUKIN-4; LEUPEPTINS; LUNG; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PYRAZINES; RECOMBINANT PROTEINS; STAT6 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33744946280     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1102     Document Type: Article

References (31)

1. Williams T. J., Sabore I., "Cytokine Reference," Vol. 1, ed. by Oppenheim J. J., Feldman M., Academic Press, San Diego, 2001, pp. 1215-1226.
2. Ponath P. D., Qin S., Post T. W., Wang J., Wu L., Gerard N. P., Newman W., Gerard C., Mackay C. R., J. Exp. Med., 183, 2437-2448 (1996).
3. Luster A. D., N. Engl. J. Med., 338, 436-445 (1998).
4. Jose P. J., Griffiths-Johnson D. A., Collins P. D., Walsh D. T., Moqbel R., Totty N. F., Truong O., Hsuan J. J., Williams T. J., J. Exp. Med., 179, 881-887 (1994).
5. Foessmann U., Uguccioni M., Loescher P., Dahinden C. A., Langen H., Thelen M., Baggiolini M., J. Exp. Med., 185, 2171-2176 (1997).
6. Shinkai A., Yoshisue H., Koike M., Shoji E., Nakagawa S., Saito A., Takeda T., Imabeppu S., Kato Y., Hanai N., Anazawa H., Kuga T., Nishi T., J. Immunol., 163, 1602-1610 (1999).
7. Zimmermann N., Hogan S. P., Mishra A., Brandt E. B., Bodette T. R., Pope S. M., Finkelman F. D. Rosenberg M. E., J. Immunol., 165, 5839-5846 (2000).
8. Vecchiarelli A., Siracusa A., Cenci E., Puliti M., Abbritti G., Clin. Exp. Allergy, 22, 365-370 (1992).
9. Wallach D., Varfolomeev E. E., Malinin N. L., Goltsev Y. V., Kovalenko A. V., Boldin M. P., Annu. Rev. Immunol., 17, 331-367 (1999).
10. Brown M. A., Pierce J. H., Watson C. J., Falco J., Ihle J. N., Paul W. E., Cell, 50, 809-818 (1987).
11. Seder R. A., Paul W. E., Ben-Sasson S. Z., LeGros G. S., Kagey S. A., Finkelman F. D., Pierce J. H., Plaut M., Int. Arch. Allergy Appl. Immunol., 94, 137-140 (1991).
12. Keegan A. D., "Cytokine Reference," Vol. 1, ed. by Oppenheim J. J., Feldmann M., Academic Press, San Diego, 2001, pp.127-135.
13. Mochizuki M., Bartels J., Mallet A. I., Christophers E., Schroder J. M., J. Immunol., 160, 60-68 (1998).
14. Stellato C., Matsukura S., Fal A., White J., Beck L. A., Proud D., Schleimer R. P., J. Immunol., 163, 5624-5632 (1999).
15. Matsukura S., Stellato C., Plitt J.R., Bickel C., Miura K., Georas S. N., Casolaro V., Schleimer R. P., J. Immunol., 163, 6876-6883 (1999).
16. Wong C. K., Zhang J. P., Ip W. K., Lam W. K., Clin. Exp. Immunol., 128, 483-489 (2002).
17. Murray R. Z., Norbury C., Anticancer Drugs, 11, 407-417 (2000).
18. Vinitsky A., Michaud C., Powers J. C., Orlowski M., Biochemistry, 31, 9421-9428 (1992).
19. Palombella V. J., Conner E. M., Fuseler J. W., Destree A., Davis J. M., Laroux F. S., Wolf R. E., Huang J., Brand S., Elliott P. J., Lazarus D., McCormack T., Parent L., Stein R., Adams J., Grisham M. B., Proc. Natl. Acad. Sci. U.S.A., 95, 15671-15676 (1998).
20. Sunwoo J. B., Chen Z., Dong G., Yeh N., Bancroft C., Sausville E., Adams J., Elliott P., Waes C. V., Clin. Cancer Res., 7, 1419-1428 (2001).
21. Hidesima T., Richardson P., Chauhan D., Palombella V. J., Elliott P. J., Adams J., Anderson K.C., Cancer Res., 61, 3071-3076 (2001).
22. Funakoshi M., Tago K., Sonoda Y., Tominaga S., Kasahara T., Biochem. Biophys. Res. Commun., 283, 248-254 (2001).
23. Matsui S., Matsumoto H., Sonoda Y., Aizu-Yokota E., Sato T., Kasahara T., Int. Immunopharmacol., 4, 1633-1644 (2004).
24. Hoeck J., Woisetschlager M., J. Immunol., 167, 3216-3222 (2001).
25. Kagami S., Saeki H., Komine M., Takanuma T., Tsunemi Y., Nakamura K., Sasaki K., Asahina A., Tamaki K., Clin. Exptl. Immunol., 141, 456-466 (2005)
26. Dulkys Y., Schramm G., Kimmig D., Knob S., Weyergraf A., Kappa A., Elsner J., J. Invest. Dermatol., 116, 498-505 (2001).
27. Komiya A., Nagase H., Yamada H., Sekiya T., Yamaguchi M., Sano Y., Hanai N., Furuya A., Ohata K., Matsushima K., Yoshie O., Yamamoto K., Hirai K., Cell. Immunol., 225, 91-100 (2003).
28. Hoeck J., Woisetschlager M., J. Immunol., 166, 4507-4515 (2001).
29. Ravensberg A. J., Ricciardolo F. L., van Schadewijk A., Rabe K. F., Sterk P. J., Hiemstra P. S., Mauad T., J. Allergy Clin. Immunol., 115, 779-785 (2005).
30. Matsui S., Sonoda Y., Sekiya T., Aizu-Yokota E., Kasahara T., Intl. Immunopharm., 6, 369-375 (2006).
31. Poynter M. E., Cloots R., van Woerkom T., Butnor K. J., Vacek P., Taatjes D. J., Irvin C. G., Janssen-Heininger Y. M., J. Immunol., 173, 7003-7009 (2004).